Business Investment Opportunities

Diagnostic center strategically located in Amtala, offering easy access to approximately 40-50 customers daily. - The lab ensures efficient and timely diagnostic services, including CT Scan, Ultrasound (USG), Echo, Digital X-ray, Holter, Endoscopy, and Pathology. - The facility is equipped with advanced medical imaging technologies with NABL accreditation and ISO certification for quality assurance and credibility. - Top-performing services include CT Scans and Ultrasounds, vital for diagnosing, monitoring, and evaluating a broad spectrum of medical conditions. - In its first year, the diagnostic center achieved significant financial success with a revenue of around 2 crore INR, reflecting strong demand for its diagnostic solutions. - Revenue generation is primarily through fee-for-service from retail patients and strategic B2B partnerships with local clinics and hospitals, enhancing referral flow and business growth.

The business is into molecular diagnostics (testing for samples for infectious diseases) - The business is also into predictive diagnostics (can test a sample of blood and can tell what chronic diseases a patient will get 5 years from the time) - Business can test a patient's sample (blood, etc) and can tell what type of cancer drugs is most suitable for a patient. - STEM cell research is also undertaken. - Promoters have 27 years of experience in this field. - Have worked in Dr. Reddys, Reliance, and Shanta Biotech. - Signed MOU's and have got some research projects with clinicians and hospitals.

Located in Lucknow, this diagnostic center specializes in offering comprehensive blood and urine tests to customers in the region. - The center processes approximately 200-250 tests each month, ensuring a steady stream of clients and services. - Average billing value per test ranges from INR 1,500 to 2,000, highlighting the center's focus on high-quality diagnostics. - The diagnostic center possesses a CMO license, ensuring compliance with health regulations and standards. - Plans for expansion include adding immunology tests and X-ray services, which will diversify the service offerings and attract more customers. - Target customers include individuals seeking diagnostic services for health assessments as well as doctors referring patients for tests. - The center operates on a B2C model, generating revenue primarily through test services, and aims to increase profitability with expansion plans.

Diagnostic center and polyclinic in Kolkata. - We plan to build an international institute of neuroscience and multisuperspeciality hospital with a research and neuro rehabilitation center in a new location hence need funds. - The company aims to focus on epilepsy and movement disorder surgery with clinical research. - We have a client base of 10,000, serving B2B, B2C, and B2G markets. - The company benefits from the promoter's 25 years of experience as a brain and spine surgeon. - We have established good business relationships and promoter experience. - The company has received multiple prestigious awards, including Outstanding Clinician in Neurosurgery, Mother Teresa Sadvabna Award, and Chikitsak Ratan Award. - Our excellent marketing team supports our growth and outreach efforts. - We plan to expand to 350 beds in the hospital. - The polyclinic currently operates with 6 doctors. - We offer a variety of tests, including neurological, cardio, ECG, and NCB, totaling 12 types of tests. - Primary revenue comes from the diagnostic center. - The company holds an incorporation license. - Current employee count is maintained with expansion plans in mind.

• We are an established healthcare provider based in Dhaka, Bangladesh, with 30 employees. • Our services include a fully integrated hospital, diagnostic, and medical checkup center, radiology & imaging, and eye care. • We have about 10,000 clients database and have seen a 20% growth rate from last year. • Committed to providing superior quality healthcare services with state-of-the-art facilities and equipment. • We have strong ties to the healthcare industry and are well-recognized in Dhaka for our operations.

Diagnostic lab based in Khulna, Bangladesh that started operations in 2017. - We provide medical testing services for urine, stool, blood, pap tests and biopsies. Also provide radiology and imaging services. - We are an independent lab and receive an average of 30 daily patients. - Providing home pickup of sample and drop of results for elderly citizens. - Owner has 7 years of experience in the healthcare industry. - Physical assets include equipment and interior setup.

Our company is essentially a biotechnology organization that sells proprietary diagnostic kits for healthcare and biotechnology research kits along with services. - These kits allow our customers to evaluate various parameters by themselves. - We have more than 40 in-house researched products. Manufacturing is done at our own premises. - Our products are sold to 32 distributors who further sell them at pharmacies and hospitals across India. Kits are also sold in Saudi Arabia, Dubai, Ukraine, Sudan and Zimbabwe. We do not sell our products directly to any customers. - Revenue plummeted this year due to the effect of the pandemic on the market. - The business is extremely valuable due to our vast array of products, IP, and enormous growth potential in the future.

Awarded by Vidharbha's Health Excellence Award. - Having more than 2.5 lakhs people as paid members. - 22 collection centers and 60 sample pickup points. - Proudly associated with Nitinji Gadkari's Khasdar Health Card in Nagpur. - Successfully provided complete health care under one roof for the last 8 years. - For other diagnoses services have tied up with 400+ doctors, 20+ hospitals, 8 diagnostics centers, 100 nurses, 12 ambulances, and blood banks. - Emerging as the largest pathology chain in Nagpur City & rural. - The promoter has more than 17 years of experience in the healthcare sector.

The business operates in the diagnostic labs industry, specifically offering laboratory and radiology services in Port Moresby. - Company currently has 5 employees and is looking to expand its services to other provinces, including the addition of dental services and the improvement of radiology services. - There is a partnership opportunity for investors to contribute to the expansion of the business and potentially benefit from the growth of the company's services. - Company receives referrals from both government hospitals and private hospitals, indicating a level of trust and recognition within the healthcare community. - We receive around 10 patients per day for consultation and tests. - Majority of the revenue comes from diagnostic lab testing. - As a relatively new business, there is potential for significant growth and market penetration, particularly in underserved areas or in the expansion of specialized services such as dental care. - Business has local licenses and registration certificates.

Business Highlights: - Founded 4 years ago, began with a COVID-19 experiment using 1,300 samples, achieving an impressive 99.77% accuracy compared to RT-PCR. - Intellectual property: Secured a patent grant, solidifying our innovative approach in AI-driven diagnostics. - Accelerator & industry recognition: Selected for The Roux Institute’s Future of Healthcare acceleration program, providing mentorship and strategic growth opportunities. - Non-dilutive & early investment traction: Gained momentum with multiple grants and secured a $50K pre-seed investment, fueling research and development. - E. coli study success: Conducted a preclinical study demonstrating 87% accuracy, further validating our RF-based pathogen detection technology. - Funding & resources: Currently leveraging USD 725K in total grants and credits, including K in USD 70 K grants received, USD 350K in Google Cloud credits, and an expected USD 305K SBIR grant from NSF. - Industry partnerships & market strategy: -- NorDx is set to be our first commercial client upon market entry. - Recognition & awards: -- Accepted into the Nvidia Inception Program for AI innovation. -- Runner-up in the AWS x Nvidia pitch competition in Austin, positioning business at the forefront of AI-powered diagnostics. - Market Launch & Revenue. - Fundraising progress: Raising USD 3M to commercialize, with USD 105K secured through SAFE notes and strong investor interest. - Business Model & Revenue Potential: Projected first-year revenue of USD 3M, with sales of 600 diagnostic units upon launch. Scalable B2B model targeting diagnostic labs, hospitals, and healthcare providers. - Potential for recurring revenue streams through AI-powered diagnostic subscriptions and consumables. - Regulatory & Clinical Traction for a Competitive Edge. Ongoing clinical validation and regulatory alignment with CLIA/CAP-accredited labs. RF-based diagnostics provide a faster, non-invasive alternative to traditional molecular testing. - With high asset valuation, driven by significant equipment costs, the company stands out in the diagnostics sector with its advanced technological infrastructure. - With a compact team of 6 skilled employees, the business emphasizes agility and innovation in its operations, facilitating quick progress in the fast-paced diagnostic technology sector.